alexa Dynamic Duo: Synergy between Cancer Radiation Therapy a
ISSN: 2471-9552

Immunotherapy: Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Dynamic Duo: Synergy between Cancer Radiation Therapy and Immunotherapy

Yuqi Zhang1 and Manchao Zhang2*

1Department of Biochemistry and Cancer Biology, the University of Toledo College of Medicine and Life Sciences, Toledo, OH 43606, USA

2Department of Radiation Oncology and Comprehensive Cancer Center, the Ohio State University, Columbus, OH43210, USA

*Corresponding Author:
Manchao Zhang
506 TMRF, 420 W.12th Ave
Columbus, OH 43210
Tel: 614-366-7501
Email: [email protected]

Received date: October 09, 2015 Accepted date: October 12, 2015 Published date: October 19, 2015

Citation: Yuqi Zhang, Manchao Zhang (2016) Dynamic Duo: Synergy between Cancer Radiation Therapy and Immunotherapy . Immunother Open Acc 2:107. doi:10.4172/2471-9552.1000107

Copyright: © 2015 Zhang Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Immunotherapy is increasingly being applied in conjunction with any of the three commonly accepted treatment modalities of surgery, chemotherapy, and radiation therapy in the treatment of solid and hematological malignancies. Radiation therapy, which can be applied as a monotherapy, has immunostimulatory properties that are specifically augmented when used together with immunotherapy. High-dose irradiation has significant effects on both the targeted tumor and the immune system that are mutually enhancing when applied appropriately. Immunogenic cell death and changes in gene expression in irradiated tumor cells fuel the immune system, allowing for immunemediated killing that leads to improved overall survival. Herein, we discussed the recent advances in radiation therapy and immunotherapy, covering myeloid-derived suppressor cells (MDSCs), radioimmunotherapy, immunocheckpoint inhibition, cancer treatment vaccine, and chimeric antigen receptor (CAR) engineered T cells and NK cells. We put forth our current understanding of the mechanisms behind how immunotherapy and radiation therapy complement each other, and suggest some topics that are worthy of further exploration.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords